Search Results - "DOROFEYEV, ANDREY E."
-
1
Clinical trial: A novel high‐dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500‐mg suppository thrice daily in active ulcerative proctitis
Published in Inflammatory bowel diseases (01-11-2010)“…Background: Mesalamine suppositories are first‐line therapy in active ulcerative proctitis; the standard regime still recommends multiple doses per day. The…”
Get full text
Journal Article -
2
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis
Published in Clinical gastroenterology and hepatology (01-01-2019)“…Although proctitis is the most limited form of ulcerative colitis, it causes unpleasant symptoms. Topical mesalamine, the standard treatment, is not always…”
Get full text
Journal Article -
3
-
4
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial
Published in Journal of Crohn's and colitis (01-04-2011)“…Budesonide may be an effective therapy for mild-to-moderately active ulcerative colitis (UC). This study aimed to demonstrate non-inferiority for oral 9mg…”
Get full text
Journal Article -
5
Sa1217 Once Daily Dosing of 9mg Budesonide (Budenofalk®) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)Get full text
Journal Article -
6
1052 Daily Mesalamine Fails to Prevent Recurrent Diverticulitis in a Large Placebo Controlled Multicenter Trial
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2014)Get full text
Journal Article -
7
Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
Published in Journal of Crohn's and colitis (01-09-2014)“…Oral budesonide 9mg/day represents first-line treatment of mild-to-moderately active ileocolonic Crohn's disease. However, there is no precise recommendation…”
Get full text
Journal Article -
8
Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome
Published in Clinical and experimental gastroenterology (01-01-2011)“…The aim of this study was to analyze the clinical efficacy and cytomorphologic changes of colon mucosa following the treatment of patients suffering from…”
Get full text
Journal Article -
9
Biochemical and Heart Adaptations to Physical Training and Supplementation With Amino Acids
Published in Journal of strength and conditioning research (01-11-2004)“…Dorofeyeva, E.E., and A.E. Dorofeyev. Biochemical and heart adaptations to physical training and supplementation with amino acids. J. Strength Cond. Res…”
Get full text
Journal Article -
10
BIOCHEMICAL AND HEART ADAPTATIONS TO PHYSICAL TRAINING AND SUPPLEMENTATION WITH AMINO ACIDS
Published in Journal of strength and conditioning research (01-11-2004)“…This study evaluated the role of amino acids supplementation on the heartʼs adaptation under extensive training conditions. Sixty active athletes (bicyclists…”
Get full text
Journal Article